CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025

08 янв 2025 08:00:01 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 08:00:01 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors

09 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

03 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 7th Annual Evercore HealthCONx Conference

21 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference

12 ноя 2024 08:00:01 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update

07 ноя 2024 07:00:01 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024

04 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference

29 окт 2024 08:00:01 Источник Nasdaq GlobeNewswire

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

16 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit

26 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference

05 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung

20 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

06 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 июл 2024 10:44:31 Источник NetDania Notify

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August

30 июл 2024 08:50:40 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

16 июл 2024 09:55:39 Источник NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

15 июл 2024 10:01:36 Источник NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 июл 2024 10:50:10 Источник NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 июн 2024 09:45:05 Источник NetDania Notify